Have a feature idea you'd love to see implemented?
Let us know!
QGEN Qiagen NV
Price (delayed)
$44.67
Market cap
$10B
P/E Ratio
120.73
Dividend/share
N/A
EPS
$0.37
Enterprise value
$10.95B
qiagen is the leading global provider of sample to insight solutions to transform biological materials into valuable molecular insights. qiagen sample technologies isolate and process dna, rna and proteins from
Highlights
Qiagen's EPS has plunged by 74% YoY but it has increased by 37% from the previous quarter
The company's net income has shrunk by 72% YoY but it rose by 28% QoQ
The price to earnings (P/E) is 44% higher than the last 4 quarters average of 83.7 and 37% higher than the 5-year quarterly average of 88.4
The debt has grown by 37% since the previous quarter and by 29% year-on-year
Key stats
What are the main financial stats of QGEN
Market
Valuations
Earnings
Shares outstanding
223.9M
Market cap
$10B
Enterprise value
$10.95B
Price to earnings (P/E)
120.73
Price to book (P/B)
2.83
Price to sales (P/S)
5.05
EV/EBIT
68.73
EV/EBITDA
29.7
EV/Sales
5.57
Revenue
$1.97B
Gross profit
$950.16M
Net income
$92.93M
EBIT
$159.31M
EBITDA
$368.6M
Free cash flow
$463.48M
Per share
Balance sheet
Liquidity
EPS
$0.37
EPS diluted
$0.37
Free cash flow per share
$2.08
Book value per share
$15.77
Revenue per share
$8.84
TBVPS
$15.53
Total assets
$6.27B
Total liabilities
$2.74B
Debt
$1.92B
Equity
$3.53B
Working capital
$1.33B
Debt to equity
0.54
Current ratio
2.17
Quick ratio
1.62
Net debt/EBITDA
2.57
Margins
Efficiency
Dividend
EBITDA margin
18.7%
Gross margin
48.3%
Net margin
4.7%
Operating margin
4.5%
Return on assets
1.6%
Return on equity
2.6%
Return on invested capital
5.5%
Return on capital employed
3.1%
Return on sales
8.1%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
QGEN stock price
How has the Qiagen stock price performed over time
Intraday
0.79%
1 week
-1.61%
1 month
6.13%
1 year
3.09%
YTD
-0.22%
QTD
-1.97%
Financial performance
How have Qiagen's revenue and profit performed over time
Revenue
$1.97B
Gross profit
$950.16M
Operating income
$89.23M
Net income
$92.93M
Gross margin
48.3%
Net margin
4.7%
Qiagen's operating income has shrunk by 78% YoY but it has increased by 20% QoQ
The operating margin has dropped by 78% year-on-year but it rose by 18% since the previous quarter
The net margin has dropped by 72% year-on-year but it has grown by 27% since the previous quarter
The company's net income has shrunk by 72% YoY but it rose by 28% QoQ
Growth
What is Qiagen's growth rate over time
Valuation
What is Qiagen stock price valuation
P/E
120.73
P/B
2.83
P/S
5.05
EV/EBIT
68.73
EV/EBITDA
29.7
EV/Sales
5.57
Qiagen's EPS has plunged by 74% YoY but it has increased by 37% from the previous quarter
The price to earnings (P/E) is 44% higher than the last 4 quarters average of 83.7 and 37% higher than the 5-year quarterly average of 88.4
The stock's price to book (P/B) is 17% less than its 5-year quarterly average of 3.4 but 4.8% more than its last 4 quarters average of 2.7
QGEN's equity is down by 4.4% YoY but it is up by 3.7% QoQ
QGEN's price to sales (P/S) is 6% lower than its 5-year quarterly average of 5.4
Efficiency
How efficient is Qiagen business performance
QGEN's ROE has plunged by 72% YoY but it is up by 30% from the previous quarter
QGEN's return on assets has dropped by 70% year-on-year but it is up by 33% since the previous quarter
Qiagen's ROS has plunged by 67% YoY but it has increased by 9% from the previous quarter
The company's return on invested capital has shrunk by 58% YoY but it rose by 10% QoQ
Dividends
What is QGEN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for QGEN.
Financial health
How did Qiagen financials performed over time
Qiagen's total assets is 129% higher than its total liabilities
The current ratio is down by 42% YoY but it is up by 23% from the previous quarter
Qiagen's quick ratio has decreased by 37% YoY but it has increased by 35% QoQ
The debt is 46% smaller than the equity
The debt has grown by 37% since the previous quarter and by 29% year-on-year
Qiagen's debt to equity has increased by 35% YoY and by 32% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.